Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Pharmacovigilance pilot study: monitoring of antidepressants with active ingredients on the market less than 5 years (duloxetine and bupropion)

  • At: 2011 FIP Congress in Hyderabad (India)
  • Type: Poster
  • By: PEñA LóPEZ, Carmen (Consejo General de Colegios Oficiales de Farmacéuticos, Madrid, Spain)
  • Co-author(s): Aliaga Pérez, Ana Mª (Consejo General de Colegios Oficiales de Farmacéuticos, Madrid, Spain)
    Amaro Cendón, Luis (Consejo General de Colegios Oficiales de Farmacéuticos, Madrid, Spain)
    Hidalgo Sotelo, Teodomiro (Consejo General de Colegios Oficiales de Farmacéuticos, Madrid, Spain)
    Recio Jaraba, Carmen (Consejo General de Colegios Oficiales de Farmacéuticos, Madrid, Spain)
    Cuéllar Rodriguez, Santiago (Consejo General de Colegios Oficiales de Farmacéuticos, Madrid, Spain)
    Martin Gutiérrez, Laura (Consejo General de Colegios Oficiales de Farmacéuticos, Madrid, Spain)
  • Abstract:

    MATERIAL AND METHODS
    The data was collected during the months of April-May 2009, by registering all the dispensation of antidepressants where the active ingredients were duloxetine or bupropion on the Pharmaceutical Care module of Bot Plus.

    RESULTS
    723 dispensations were collected, 660 for duloxetine and 63 for bupropion.
    The standard patient was a

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses